Panzyga is a Intravenous Solution in the Plasma Derivative category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Human Immunoglobulin G.
Product ID | 0069-1415_070501cc-8328-4bc3-91c8-8688fba3f982 |
NDC | 0069-1415 |
Product Type | Plasma Derivative |
Proprietary Name | Panzyga |
Generic Name | Immune Globulin Intravenous (human) |
Dosage Form | Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2019-08-09 |
Marketing Category | BLA / BLA |
Application Number | BLA125587 |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | HUMAN IMMUNOGLOBULIN G |
Active Ingredient Strength | 100 mg/mL |
Pharm Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2019-08-09 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125587 |
Product Type | LOT DISTRIBUTION DATA |
Billing Unit | ML |
Marketing Start Date | 2019-08-09 |
Marketing Category | BLA |
Application Number | BLA125587 |
Product Type | LOT DISTRIBUTION DATA |
Billing Unit | ML |
Marketing Start Date | 2019-08-09 |
Ingredient | Strength |
---|---|
HUMAN IMMUNOGLOBULIN G | 100 mg/mL |
NDC | Brand Name | Generic Name |
---|---|---|
0069-1011 | Panzyga | immune globulin intravenous (human) |
0069-1109 | Panzyga | immune globulin intravenous (human) |
0069-1224 | Panzyga | immune globulin intravenous (human) |
0069-1312 | Panzyga | immune globulin intravenous (human) |
0069-1415 | Panzyga | immune globulin intravenous (human) |
0069-1558 | Panzyga | immune globulin intravenous (human) |
68982-820 | Panzyga | immune globulin intravenous (human) |
68982-822 | Panzyga | immune globulin intravenous (human) |
61953-0005 | FLEBOGAMMA DIF | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) |
0944-2623 | GAMMAGARD | Immune Globulin Intravenous (Human) |
0944-2625 | GAMMAGARD | Immune Globulin Intravenous (Human) |
0944-2627 | GAMMAGARD | Immune Globulin Intravenous (Human) |
0944-2656 | GAMMAGARD | Immune Globulin Intravenous (Human) |
0944-2658 | GAMMAGARD | Immune Globulin Intravenous (Human) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PANZYGA 79148226 4630483 Live/Registered |
Octapharma AG 2014-04-03 |